Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It would certainly be an accomplishment if one or both of those stocks could make some of the board members rich.
G' day Mates,
Aussie
AND, COULD THIS ALSO BE ANOTHER FUTURE UNDISCOVERED STOCK TO KEEP YOUR EYE ON? Give me your thoughts, please!
This PR hasn't hit some boards yet. Got it as an email from the company a few minutes ago.
Signalife Completes Testing of Modules for Holter and Intra-Cardiac Monitor
LOS ANGELES, Oct 01, 2007 /PRNewswire-FirstCall via COMTEX/ -- Signalife,Inc. (Amex: SGN - News) has announced that is has completed in-house testing and technological evaluation of various new modules for its holter and intra- cardiac monitors - items that have previously been an important part of the Company's business plans and are now ready for submission to FDA for clearance. Applications for FDA approval will now be made
imminently in the fourth quarter.
Both of these developments are ahead of schedule, and are of importance because they are both revenue producing as well as scientifically significant to the reduction of the $400 billion in cardiovascular expenses as well as to patient health and welfare. Having them completed ahead of schedule will likely bring these products to the forefront several quarters earlier than anticipated - both from a revenue standpoint
as well as a scientific venturing standpoint.
------------------------
G' day Mates,
Aussie
COULD THIS BE THE NEXT BIG UNDISCOVERED STOCK?
Got this today in an eamil from the company.
http://ir.puredepth.com/releaseDetail.cfm?ReleaseID=266672
Samsung Signs Exclusive License for PureDepth's MLD Technology for Mass Market Applications
Samsung Signs Exclusive License for PureDepth's MLD Technology for Mass Market Applications
REDWOOD SHORES, Calif., Oct 01, 2007 (BUSINESS WIRE) -- Samsung Electronics Corporation (KSE:005930) (LSE:SMSN) and PureDepth(TM), Inc. (OTC:PDEP), a global leader in next-generation display technologies and the pioneer of multi-layer display (MLD(TM)) technology, today announced that Samsung has licensed PureDepth's technology for use in a wide array of consumer products that includes computer monitors, TVs, and public information displays. The license is based on a per unit royalty with initial shipments targeted for 2008. Under this worldwide exclusive license agreement, excluding Japan, Samsung will be responsible for all of the manufacturing, marketing and distribution of products integrating MLD technology.
"We're very pleased to be working with Samsung under such a wide-ranging agreement," said Thomas L. Marcus, Chairman and CEO of PureDepth. "As the market leader for display products, Samsung is the perfect partner to bring our technology to the mass market."
--------------------
G'day mates,
Aussie
AND, COULD THIS ALSO BE A FUTURE TASTY BOOSHER TO KEEP YOUR EYE ON. Give me your thoughts, please!
This PR hasn't hit some boards yet. Got it as an email from the company a few minutes ago.
Signalife Completes Testing of Modules for Holter and Intra-Cardiac Monitor
LOS ANGELES, Oct 01, 2007 /PRNewswire-FirstCall via COMTEX/ -- Signalife,Inc. (Amex: SGN - News) has announced that is has completed in-house testing and technological evaluation of various new modules for its holter and intra- cardiac monitors - items that have previously been an important part of the Company's business plans and are now ready for submission to FDA for clearance. Applications for FDA approval will now be made
imminently in the fourth quarter.
Both of these developments are ahead of schedule, and are of importance because they are both revenue producing as well as scientifically significant to the reduction of the $400 billion in cardiovascular expenses as well as to patient health and welfare. Having them completed ahead of schedule will likely bring these products to the forefront several quarters earlier than anticipated - both from a revenue standpoint
as well as a scientific venturing standpoint.
------------------------
G' day Mates,
Aussie
Could this be the next trendfinder?
Got this today in an email from the company.
http://ir.puredepth.com/releaseDetail.cfm?ReleaseID=266672
Samsung Signs Exclusive License for PureDepth's MLD Technology for Mass Market Applications
Samsung Signs Exclusive License for PureDepth's MLD Technology for Mass Market Applications
REDWOOD SHORES, Calif., Oct 01, 2007 (BUSINESS WIRE) -- Samsung Electronics Corporation (KSE:005930) (LSE:SMSN) and PureDepth(TM), Inc. (OTC:PDEP), a global leader in next-generation display technologies and the pioneer of multi-layer display (MLD(TM)) technology, today announced that Samsung has licensed PureDepth's technology for use in a wide array of consumer products that includes computer monitors, TVs, and public information displays. The license is based on a per unit royalty with initial shipments targeted for 2008. Under this worldwide exclusive license agreement, excluding Japan, Samsung will be responsible for all of the manufacturing, marketing and distribution of products integrating MLD technology.
"We're very pleased to be working with Samsung under such a wide-ranging agreement," said Thomas L. Marcus, Chairman and CEO of PureDepth. "As the market leader for display products, Samsung is the perfect partner to bring our technology to the mass market."
--------------------
G'day mates,
Aussie
Ye, However, I will try to repost it to see what transpires.
Thank you Obi for your reply.
G' day Mate,
Aussie
Board monitors. I had a post removed this morning and haven't a clue as to why. It was alerting the board to what I felt was a future trendfinder based on a PR that was just released this morning. And, the PPS on the stock had moved up.
Thanks for any help.
G' day Mates,
Aussie
EP...Thanks.I didn't think it was you. Just wanted to make sure. I know who is to blame; but, he won't tell me. Still angry for something over a year ago.
G' day Mate,
Aussie
Ep...My post #26038 on Signalife was removed. I thought it was a good Tasty Boosher. Can you give me an explanation as to why it was removed? I want to avoid it from happening in the future.
Thanks.
G' day Mate,
Aussie
Press Release Source: Signalife, Inc.
NFL Hall of Fame Legend Fred Biletnikoff joins
AFL/Signalife Cardiovascular Protection Team
Wednesday September 25, 2007
LOS ANGELES, Sep. 25 /PRNewswire-FirstCall/ -- NFL Hall of Fame, legendary wide receiver, Fred Biletnikoff, has joined the ever-growing team of celebrated athletes and entertainers as a part of the cardiovascular protection team of Signalife, Inc. (Amex: SGN - News) and Athletes for Life (“AFL”), using Signalife’s Fidelity 100 and its related products and technologies. He has joined such superstars as Joe Theisman, Marshall Faulk, Tim Brown, Rocket Ismail, Jerry Rice, Dwight Clark, and Leonard Marshall in putting down their collective feet to put a stop to the late-stage, inaccurate-diagnosis-laden (diagnoses which is sometimes too little too late) assessment of heart and cardiovascular diseases.
The MVP of Super Bowl XI, Mr. Biletnikoff demonstrated on a world stage what passion and focus mean as he delivered an unprecedented performance in leading his team to an overwhelming victory in the Super Bowl.
In 1999, Mr. Biletnikoff was ranked number 94 on The Sporting News “list of the 100 Greatest Football Players.” The Fred Biletnikoff Award, awarded annually to the best wide receiver in college football since 1994, was named in his honor.
Dr. Harmison, former Principal Deputy of the U.S. Department of Health Services, commented: “Mr. Biletnikoff – one of my personal heroes – has made the choice to make a difference in a disease-state that burdens practically every family in America and costs the U.S. Health Care industry about $400 billion per year in treating cardiovascular disease. Having someone of his stature – a true NFL legend – and of his demographic, will assist Signalife and AFL in addressing all of the different possible disease states and treatment options in a wider array of circumstances. I very much appreciate Mr. Biletnikoff’s decision to join our cause to level the playing field for everyone.”
About Signalife
Signalife, Inc. is a life sciences company focused on the monitoring and detection of disease through continuous biomedical signal monitoring. Signalife uses its patented signal technology to design and develop medical devices that simplify and reduce the costs of diagnostic testing and patient monitoring in an ambulatory setting.
Signalife is publicly traded on the American Stock Exchange under the symbol SGN. The website for the company is http://www.Signalife.com. Clear Data. Trusted Results.
Caution Regarding Forward-Looking Statements Statements in this release that are not strictly historical are "forward-looking" statements. Forward-looking statements involve known and unknown risks, which may cause Signalife's actual results in the future to differ materially from expected results. Factors which could cause or contribute to such differences include, but are not limited to, failure to complete the development and introduction of heart monitoring and other biomedical devices incorporating Signalife's technology, failure to obtain federal or state regulatory approvals governing heart monitoring and other biomedical devices incorporating Signalife's technology, inability to obtain physician, patient or insurance acceptance of for heart monitoring and other biomedical incorporating Signalife's technology, and the unavailability of financing to complete management's plans and objectives, including the development of heart monitoring and other biomedical incorporating Signalife's technology. These risks are qualified in their entirety by cautionary language and risk factors set forth and to be further described in Signalife's filings with the Securities and Exchange Commission.
Contact: Kevin Kading for Signalife, Inc., (212)-918-4606
Source: Signalife, Inc.
------------------------
G' day Mates,
Aussie
John wayne...FASC isn't a bottom buster I'd go after. It has had far too many dilutions and wouldn't be surprised if one were on the horizon. I can give you a list of FASC PRs that have not come about since 1982. Some have been even repeated in countries like Japan and Poland. The 30 machines in 6 years in Malaysia is a joke.
http://ragingbull.quote.com/mboard/boards.cgi?board=FASC&read=204824
FASC has a poor record of following up on any of their PRs. What happens is they usually just don't report them in the quarterly reports and their forgotten, only to be replaced by new PRs that eventually experience the same fate.
One to definitely stay away from.
IMO.
G' day Mate,
Aussie
bigcoinman...ASTM has settled down. Looks to close up $.06. The volume was erratic for the day and after 12:30 most trades were small. Also checked the Williams %R, OnBalanceVolume and 10, 20 & 30 day SMA charts. None show any good signs for the stock.
G' day Mate,
Aussie
I love it when they play follow the real leaders. LOL.
Of course...
IMO,
Aussie
Either that or I force my presence. Nah! I like the way you phrase it better.
G' day Mate,
Aussie
Obi...Good detective work, huh? I had posted on several boards the same two messages; however, somehow I knew you were the thankful one.
Thanks again.
G' day Mate,
Aussie
Obi..If you're the one that gave me the member mark just now, thank you. I'll give one in reurn.
G' day Mate,
Aussie
Obi_Penny_Kanobi...Thanks. I already have several and have full intentions of buying some more. I was waiting for positive PRs like the last two.
G' day Mate,
Aussie
PureDepth - Several Technology Exhibitions & Tradeshows
REDWOOD SHORES, Calif., Sep 25, 2007 (BUSINESS WIRE) -- PureDepth(TM), Inc. (OTC: PDEP), a global leader in next-generation display technologies and the pioneer of Multi-Layer Display (MLD(TM)) technology, announced today that it will be presenting its MLD technology at several technology exhibitions and tradeshows in October and November 2007.
PureDepth's upcoming conference schedule is as follows:
Flat Panel Display International, the Leading International Exhibition and Forum on Flat Panel Display (FPD), in Yokohama Japan October 23rd - 25th. FPDI is a forum for the leading manufacturers of flat panel displays to discuss the future of the technology. PureDepth will have a booth at the show to demonstrate MLD-based solutions from location-based entertainment, computer monitors, public displays, and mobile devices. On display will be a 46" MLD prototype for use in public displays and other large format devices like flat panel televisions.
6Sight, the Future of Imaging, in Monterey, California November 8th - 9th. Mark Yahiro, PureDepth's Senior Vice President of Marketing and Business Development, will be presenting the Company's MLD technology and speaking about new natural interfaces at this conference on the future of imaging technology. The conference offers insight from imaging industry experts as well as showcases new products and technologies in development. Attendees include top innovators, researchers, developers, and marketers of imaging technology.
G2E, Global Gaming Expo, November 13th - 15th in Las Vegas, Nevada. G2E is an exhibition of the latest products, technologies and innovations in gaming. PureDepth will showcase its MLD technology to leaders in the gaming and gaming technology industries.
"These events highlight the development of PureDepth's MLD technology and allow us to display its application in multiple products across different markets. These are significant opportunities for us to demonstrate the enhanced visual experience to users as well as the ease of integration into LCD products to manufacturers," said Thomas L. Marcus, CEO of PureDepth.
About PureDepth
PureDepth (www.puredepth.com) is an innovative technology company transforming the visual display experience by delivering award-winning MLD technology. Backed by 49 approved patents and over 80 pending patents, this breakthrough in visualization is the first display technology that provides Actual Depth(TM). The Company has a sales, marketing and distribution license agreement with Sanyo Corporation (NASDAQ: SANYY) in Japan, a worldwide licensing agreement with International Game Technology (NYSE: IGT) and business opportunities in broad consumer markets. Founded in 1999, the Company is headquartered in Redwood Shores, California, with a research and development center located in New Zealand and offices in Japan.
Forward-Looking Statements
This press release contains certain statements that are "forward-looking statements" and includes, among other things, discussions and disclosures of the Company's expectations for the use of its technology and market for its products, and the likelihood of any resulting products to become widely accepted by the marketplace. Words such as, but not limited to, "may," "likely," "anticipate," "expect" and "believes" indicate forward-looking statements. Although PureDepth believes that the expectations reflected in these forward-looking statements are generally reasonable, it can give no assurance that such expectations will ultimately prove to be correct or materialize. All phases of PureDepth's business and operations are subject to a number of uncertainties, risks and other influences, most of which are outside its control, and any one or combination of which could materially and adversely affect the results of the Company's operations, and whether any forward-looking statements contained herein ultimately prove to be accurate. Information regarding such risks and uncertainties can be found in the Company's most recently filed annual report on 10-KSB and other filings that have been made with the SEC.
PureDepth(TM), MLD(TM) and Actual Depth(TM) are trademarks of PureDepth, Inc. All other trademarks and registered trademarks are the property of their respective owners, without intent to infringe.
SOURCE: PureDepth, Inc.
PR:
Maloney & Fox, LLC
Zac Rivera, 646-356-8312
zrivera@maloneyfox.com
or
Investor Relations:
PureDepth, Inc.
Ashton Partners, 650-361-0480
investor-relations@puredepth.com
-----------------------------
G' day Mates,
Aussie
Press Release Source: Signalife, Inc.
Signalife Receives Another $3.3 Million Sales Orders
Tuesday September 25, 2007
LOS ANGELES, Sept. 25 /PRNewswire-FirstCall/ -- Earlier today, Signalife announced that it has received additional orders for the sale of $3.3 million (three million three hundred thousand dollars) of Fidelity 100 units as a continued result of new management’s initial sales campaign.
In the words of Signalife’s President, Dr. Harmison, “that is $5.28 million of sales orders of our Fidelity 100 since I took over operational control of the Company, and – as we fulfill our existing orders – the Company will continue its efforts and expects to add additional sales to the system shortly.”
About Signalife:
Signalife, Inc. is an award-winning life sciences company focused on the monitoring and detection of disease through continuous biomedical signal monitoring. Signalife uses its patented signal technology to design and develop medical devices that simplify and reduce the costs of diagnostic testing and patient monitoring in an ambulatory setting. Signalife is
publicly traded on the American Stock Exchange under the symbol SGN. The website for the company is http://Signalife.com. Clear Data. Trusted Results.
Caution Regarding Forward-Looking Statements:
Statements in this release that are not strictly historical are "forward-looking" statements. Forward-looking statements involve known and unknown risks, which may cause Signalife's actual results in the future to differ materially from expected results. Factors which could cause or contribute to such differences include, but are not limited to, failure to complete
the development and introduction of heart monitoring and other biomedical devices incorporating Signalife's technology, failure to obtain federal or state regulatory approvals governing heart monitoring and other biomedical devices incorporating Signalife's technology, inability to obtain physician, patient or insurance acceptance of for heart monitoring and other biomedical incorporating Signalife's technology, and the
unavailability of financing to complete management's plans and objectives,including the development of heart monitoring and other biomedical incorporating Signalife's technology. These risks are qualified in their entirety by cautionary language and risk factors set forth and to be further described in Signalife's filings with the Securities an Exchange
Commission.
Contact: Kevin Kading for Signalife, Inc., (212)-918-4606
Source: Signalife, Inc.
---------------------
G' day Mates,
Aussie
PureDepth - Several Technology Exhibitions & Tradeshows
REDWOOD SHORES, Calif., Sep 25, 2007 (BUSINESS WIRE) -- PureDepth(TM), Inc. (OTC: PDEP), a global leader in next-generation display technologies and the pioneer of Multi-Layer Display (MLD(TM)) technology, announced today that it will be presenting its MLD technology at several technology exhibitions and tradeshows in October and November 2007.
PureDepth's upcoming conference schedule is as follows:
Flat Panel Display International, the Leading International Exhibition and Forum on Flat Panel Display (FPD), in Yokohama Japan October 23rd - 25th. FPDI is a forum for the leading manufacturers of flat panel displays to discuss the future of the technology. PureDepth will have a booth at the show to demonstrate MLD-based solutions from location-based entertainment, computer monitors, public displays, and mobile devices. On display will be a 46" MLD prototype for use in public displays and other large format devices like flat panel televisions.
6Sight, the Future of Imaging, in Monterey, California November 8th - 9th. Mark Yahiro, PureDepth's Senior Vice President of Marketing and Business Development, will be presenting the Company's MLD technology and speaking about new natural interfaces at this conference on the future of imaging technology. The conference offers insight from imaging industry experts as well as showcases new products and technologies in development. Attendees include top innovators, researchers, developers, and marketers of imaging technology.
G2E, Global Gaming Expo, November 13th - 15th in Las Vegas, Nevada. G2E is an exhibition of the latest products, technologies and innovations in gaming. PureDepth will showcase its MLD technology to leaders in the gaming and gaming technology industries.
"These events highlight the development of PureDepth's MLD technology and allow us to display its application in multiple products across different markets. These are significant opportunities for us to demonstrate the enhanced visual experience to users as well as the ease of integration into LCD products to manufacturers," said Thomas L. Marcus, CEO of PureDepth.
About PureDepth
PureDepth (www.puredepth.com) is an innovative technology company transforming the visual display experience by delivering award-winning MLD technology. Backed by 49 approved patents and over 80 pending patents, this breakthrough in visualization is the first display technology that provides Actual Depth(TM). The Company has a sales, marketing and distribution license agreement with Sanyo Corporation (NASDAQ: SANYY) in Japan, a worldwide licensing agreement with International Game Technology (NYSE: IGT) and business opportunities in broad consumer markets. Founded in 1999, the Company is headquartered in Redwood Shores, California, with a research and development center located in New Zealand and offices in Japan.
Forward-Looking Statements
This press release contains certain statements that are "forward-looking statements" and includes, among other things, discussions and disclosures of the Company's expectations for the use of its technology and market for its products, and the likelihood of any resulting products to become widely accepted by the marketplace. Words such as, but not limited to, "may," "likely," "anticipate," "expect" and "believes" indicate forward-looking statements. Although PureDepth believes that the expectations reflected in these forward-looking statements are generally reasonable, it can give no assurance that such expectations will ultimately prove to be correct or materialize. All phases of PureDepth's business and operations are subject to a number of uncertainties, risks and other influences, most of which are outside its control, and any one or combination of which could materially and adversely affect the results of the Company's operations, and whether any forward-looking statements contained herein ultimately prove to be accurate. Information regarding such risks and uncertainties can be found in the Company's most recently filed annual report on 10-KSB and other filings that have been made with the SEC.
PureDepth(TM), MLD(TM) and Actual Depth(TM) are trademarks of PureDepth, Inc. All other trademarks and registered trademarks are the property of their respective owners, without intent to infringe.
SOURCE: PureDepth, Inc.
PR:
Maloney & Fox, LLC
Zac Rivera, 646-356-8312
zrivera@maloneyfox.com
or
Investor Relations:
PureDepth, Inc.
Ashton Partners, 650-361-0480
investor-relations@puredepth.com
-----------------------------
G' day Mates,
Aussie
Press Release Source: Signalife, Inc.
Signalife Receives Another $3.3 Million Sales Orders
Tuesday September 25, 2007
LOS ANGELES, Sept. 25 /PRNewswire-FirstCall/ -- Earlier today, Signalife announced that it has received additional orders for the sale of $3.3 million (three million three hundred thousand dollars) of Fidelity 100 units as a continued result of new management’s initial sales campaign.
In the words of Signalife’s President, Dr. Harmison, “that is $5.28 million of sales orders of our Fidelity 100 since I took over operational control of the Company, and – as we fulfill our existing orders – the Company will continue its efforts and expects to add additional sales to the system shortly.”
About Signalife:
Signalife, Inc. is an award-winning life sciences company focused on the monitoring and detection of disease through continuous biomedical signal monitoring. Signalife uses its patented signal technology to design and develop medical devices that simplify and reduce the costs of diagnostic testing and patient monitoring in an ambulatory setting. Signalife is
publicly traded on the American Stock Exchange under the symbol SGN. The website for the company is http://Signalife.com. Clear Data. Trusted Results.
Caution Regarding Forward-Looking Statements:
Statements in this release that are not strictly historical are "forward-looking" statements. Forward-looking statements involve known and unknown risks, which may cause Signalife's actual results in the future to differ materially from expected results. Factors which could cause or contribute to such differences include, but are not limited to, failure to complete
the development and introduction of heart monitoring and other biomedical devices incorporating Signalife's technology, failure to obtain federal or state regulatory approvals governing heart monitoring and other biomedical devices incorporating Signalife's technology, inability to obtain physician, patient or insurance acceptance of for heart monitoring and other biomedical incorporating Signalife's technology, and the
unavailability of financing to complete management's plans and objectives,including the development of heart monitoring and other biomedical incorporating Signalife's technology. These risks are qualified in their entirety by cautionary language and risk factors set forth and to be further described in Signalife's filings with the Securities an Exchange
Commission.
Contact: Kevin Kading for Signalife, Inc., (212)-918-4606
Source: Signalife, Inc.
---------------------G' day Mates,
aussie
Doubloon...Thanks for the email.
G' day Mate,
Aussie
Looking over the SB-2, it does give some insight into their other projects.
We are also currently working on a number of products using our proprietary signal acquisition and amplification technology that are in the late development stage and which we expect to introduce to market in either late 2007 or by the end of 2008. These products include the Signalife “ Fidelity 200 Event Recording
System ” or “ Fidelity 200 ”, the Signalife “ Fidelity 300 Holder Monitor ” or “ Fidelity 300 ”, the Signalife “ Fidelity 400 Intracardiac Monitor ” or “ Fidelity 400 ”, and the Signalife Cardiac Vest .
The Signalife Fidelity 200 Event Recording System is a direct-to-consumer non-prescription credit card-sized heart monitoring device which has been specifically designed to be used in conjunction with monitoring centers. We anticipate that we will sell the Fidelity 200 to consumers through retail outlets such as drug stores, retail pharmacies, and major retail discount chains. The consumer will then separately subscribe to a monitoring service that is compatible with the device. We anticipate that the production version will be completed and brought to market by the end of fiscal 2007.
The Fidelity 300 is a three-lead ambulatory Holter monitor which will be used while the patient carries out his or her daily activities away from the physicians’ office or hospital to collect ECG data relating to arrhythmia and other transient heart disease. Specifically, the data is acquired, processed, amplified and stored in a computer storage chip contained in the Fidelity 300 , and then downloaded by the physician at a later date when the patient returns to the physician’s office. The Fidelity 300 will allow up to thirty days of data to be recorded, satisfying physician needs for a more extensive database, unlike other Holter markets currently on the market that record only for a period of 24 to 48 hours. We anticipate a production version of this product will be completed and brought to market at the end of 2008 at the earliest.
The Signalife Cardiac Vest , developed in conjunction with the Champ Car World Series, is an extremely lightweight, close-fitting vest that will be used as a more effective, convenient and comfortable alternative for the electrode and lead sets customarily used with ambulatory cardiac monitors. The design is planned to allow a patient to use the vest on a 24/7 basis for extended periods of time, being removed only intermittently for showers, etc. We anticipate a production version of this product will be completed and brought to market at the end of 2008 at the earliest.
We are also actively pursuing other marketing alternatives. For example, we have recently successfully completed a pilot program in which patrons of a gym were tested using the Fidelity 100 in order to detect and identify cardiovascular disease that could be triggered or exacerbated by exercise programs. We are now in the process of expanding the program to fitness facilities across the country. We are also participating in the Athletes For Life program which will focus on developing protocols to test professional and amateur athletes for cardiovascular disease and abnormalities as part of their regular training regime, and will also promote testing for impoverished communities where early detection of cardiovascular disease simply does not exist.
---------------------------
One can only hope and dream.
G' nite Mate,
Aussie
Jagman...Must admit I was completely unaware of the SB-2 filing. However, that was before the company PR dated 20 Sept. 2007, so maybe it was a mixture of both that are causing the increase of volume in the last couple of week and the PPS rising.
Here's that PR in case you missed it:
Signalife Achieves $1.98 Million Sales Orders Thus Far
LOS ANGELES, Sept 20, 2007 /PRNewswire-FirstCall via COMTEX/ -- Signalife announced today that it has received orders for the sale of nearly $2,000,000 (two million dollars) of Fidelity 100 units thus far in its initial sales push being led by new management. Signalife, which anticipates additional sales orders resulting from its current efforts,shall announce such sales as and when they are completed.
About Signalife: Signalife, Inc. is an award-winning life sciences company focused on the monitoring and detection of disease through continuous biomedical signal monitoring. Signalife uses its patented signal technology to design and
develop medical devices that simplify and reduce the costs of diagnostic testing and patient monitoring in an ambulatory setting. Signalife is publicly traded on the American Stock Exchange under the symbol SGN. The website for the company is http://Signalife.com. Clear Data. Trusted Results.
Caution Regarding Forward-Looking Statements: Statements in this release that are not strictly historical are "forward-looking" statements. Forward-looking statements involve known and unknown risks, which may cause Signalife's actual results in the future to differ materially from expected results. Factors which could cause or contribute to such differences include, but are not limited to, failure to complete the development and introduction of heart monitoring and other biomedical devices incorporating Signalife's technology, failure to obtain federal or state regulatory approvals governing heart monitoring and other biomedical devices incorporating Signalife's technology, inability to obtain physician, patient or insurance acceptance of for heart monitoring and other biomedical incorporating Signalife's technology, and the unavailability of financing to complete management's plans and objectives,including the development of heart monitoring and other biomedical
incorporating Signalife's technology. These risks are qualified in their entirety by cautionary language and risk factors set forth and to be further described in Signalife's filings with the Securities an Exchange Commission.
SOURCE Signalife, Inc.
-------------------------
G' day Mate,
Aussie
Jagman...Been watching it and have no clue as to why it's moving. There is no news out there yet. The volume has been climbing the last couple days; but, not enough to suggest institutional buying of any sort.
G' day Mate,
Aussie
Another to consider and, it has done much better recently. Since late August it has gone from $.80 to $1.30. However, please do your DD.
The company site
http://www.signalife.com/index.asp
Recent PR shows things may be looking up.
http://www.signalife.com/Pages/NewsPDF/2007/PR09202007.asp
Thursday September 20, 9:03 am ET
Signalife Achieves $1.98 Million Sales Orders Thus Far
LOS ANGELES, Sep. 20 /PRNewswire-FirstCall/ -- Signalife announced today that it has received orders for the sale of nearly $2,000,000 (two million dollars) of Fidelity 100 units thus far in its initial sales push being led by new management. Signalife, which anticipates additional sales orders resulting from its current efforts, shall announce such sales as and when they are completed.
9/6/07 · Legendary Earvin 'Magic' Johnson Joins AFL/Signalife Cardiovascular Protection Team - PR Newswire
This is just a PR. Didn't raise the PPS
http://money.aol.com/news/articles/_a/legendary-earvin-magic-johnson-joins/n20070906090709990014
9/4/07 · Signalife to Deploy Fidelity 100 Heart Monitors for AFL - PR Newswire
This was a good follow-up PR.
http://money.aol.com/news/articles/_a/signalife-to-deploy-fidelity-100-heart/n20070904105209990030
8/20/07 · Signalife Completes $102 Million Financing - PR Newswire
THIS IS THE PR! It clearly shows someone believes in the technology and puts the money up.
http://money.aol.com/news/articles/_a/signalife-to-deploy-fidelity-100-heart/n20070904105209990030
Signalife Completes $102 Million Financing
LOS ANGELES, Aug. 20 /PRNewswire-FirstCall/ -- Signalife, Inc. (Amex: SGN - News) has just released to the news wires that it has received American Stock Exchange Approval for up to $102 million in financing with Yorkville Advisors, LLC through its YA Global Investments LP fund.
As part of the financing, Signalife has received immediate funding of $2 million through the sale of its common stock to YA Global Investments, and has also entered into a Standby Equity Distribution Agreement (SEDA) allowing Signalife, at its sole discretion upon effectiveness of a registration statement relating to the shares underlying the SEDA, to sale up to $100 million in additional common stock to YA Global Investments over the next three years. The company shall now proceed forward with its newly constituted Board and immediate sales initiative. The market should expect a status conference call from President and former FDA-head Lowell Harmison later this month or immediately after Labor Day.
When Dr. Harmison took the post, he promised immediate financing and he has delivered.
-------------------------------
G' day Mates,
Aussie
Here's one to consider. PDEP. It has promising technology. But, like any penny stock, one must do their DD on it.
Today's PR from the company
PureDepth Secures Base Patent in China
BUSINESS WIRE
Posted: 2007-09-21 08:21:43
REDWOOD SHORES, Calif.--(BUSINESS WIRE)----PureDepth(TM), Inc. (OTC: PDEP), a global leader in next-generation display technologies and the pioneer of Multi-Layer Display (MLD(TM)) technology, today announced that it has been granted a patent for its base technology in China. The Chinese Patent Office awarded the Patent, Number 98813714.3, which encompasses the core technology upon which PureDepth's technology is developed. PureDepth's technology is now backed by a total of 49 granted patents.
http://money.aol.com/news/articles/_a/puredepth-secures-base-patent-in-china/n20070921082109990025
This is not a good report by any stretch of the imagination
PureDepth Announces Second Quarter Results
BUSINESS WIRE
Posted: 2007-09-17 08:23:20
REDWOOD SHORES, Calif.--(BUSINESS WIRE)----PureDepth(TM), Inc. (OTCBB: PDEP), a global leader in next-generation display technologies and the pioneer of Multi-Layer Display (MLD(TM)) technology, today announced financial results for the quarter and six months ended July 31, 2007.
"We feel we've made significant progress this quarter on our goal of getting our technology to the mass market. We continue to work closely with our existing licensing partners Sanyo and IGT to develop products for the location based entertainment markets and we continue to develop relationships with major LCD manufacturers that we believe will lead to the establishment of our MLD technology in various other markets including, computer monitors, public displays, mobile phones, automotive and televisions. We are confident that we will attain our goal of placing PureDepth's MLD technology in key markets worldwide," said Thomas L. Marcus, PureDepth's Chairman and CEO.
The Company reported total revenue of $308,719 for the second quarter ended July 31, 2007 of which $187,500 was revenue generated from technology licensing and $121,219 of revenue was generated from sales of products and services. The Company also reported a net loss of $2,807,076 or $0.04 per common share compared to a loss of $1,854,304 or $0.04 per common share for the same period of the previous fiscal year. The increase in the net loss was due primarily to increased costs associated with personnel and personnel related expenses for business development and engineering as well as professional services relating to public company filing requirements.
For the six months ended July 31, 2007, the Company reported total revenue of $540,317 and a net loss of $4,785,320, or $0.07 per share compared with a net loss of $5,531,854 for same six month period of the previous year, or $0.12 per share.
As of July 31, 2007, the Company reported cash and cash equivalents of $3,227,962 and marketable securities of $1,013,178.
http://money.aol.com/news/articles/_a/puredepth-announces-second-quarter/n20070917082309990019
This is their big fish.
http://ir.puredepth.com/releasedetail.cfm?ReleaseID=214922REDWOOD SHORES, Calif., Oct 17, 2006 (BUSINESS WIRE) -- PureDepth(TM), Inc. (OTC: PDEP), a leader in next-generation display technologies and the pioneer of multi-layer display (MLD(TM)) technology, today announced a worldwide agreement with International Game Technology (NYSE: IGT), a leading international provider of computerized, gaming machines and systems products.
Under the agreement, IGT is licensing PureDepth technology and patents in order to develop, manufacture, market, sell and distribute products for use in wager-based gaming. The license is worldwide (excluding Japan).
----------------------
G' day Mates,
Aussie
Knock! Knock! Any body home? This is Mr. Opportunity and I'm here to tell you about some terrific deals. Wait a minute. That's the line for a car deal. Didn't think you'd fall for that.
G' day Mates,
Aussie
I see this is an OTC board. Am I to take it no pennies over a dollar should be posted as they are not really bottom dwellers?
Thanks,
G' day Mates,
Aussie
$treet Trader...Thank you.
G' day Mate,
Aussie
Another to consider and, it has done much better recently. Since late August it has gone from $.80 to $1.30. However, please do your DD.
The company site
http://www.signalife.com/index.asp
Recent PR shows things may be looking up.
http://www.signalife.com/Pages/NewsPDF/2007/PR09202007.asp
Thursday September 20, 9:03 am ET
Signalife Achieves $1.98 Million Sales Orders Thus Far
LOS ANGELES, Sep. 20 /PRNewswire-FirstCall/ -- Signalife announced today that it has received orders for the sale of nearly $2,000,000 (two million dollars) of Fidelity 100 units thus far in its initial sales push being led by new management. Signalife, which anticipates additional sales orders resulting from its current efforts, shall announce such sales as and when they are completed.
9/6/07 · Legendary Earvin 'Magic' Johnson Joins AFL/Signalife Cardiovascular Protection Team - PR Newswire
This is just a PR. Didn't raise the PPS
http://money.aol.com/news/articles/_a/legendary-earvin-magic-johnson-joins/n20070906090709990014
9/4/07 · Signalife to Deploy Fidelity 100 Heart Monitors for AFL - PR Newswire
This was a good follow-up PR.
http://money.aol.com/news/articles/_a/signalife-to-deploy-fidelity-100-heart/n20070904105209990030
8/20/07 · Signalife Completes $102 Million Financing - PR Newswire
THIS IS THE PR! It clearly shows someone believes in the technology and puts the money up.
http://money.aol.com/news/articles/_a/signalife-to-deploy-fidelity-100-heart/n20070904105209990030
Signalife Completes $102 Million Financing
LOS ANGELES, Aug. 20 /PRNewswire-FirstCall/ -- Signalife, Inc. (Amex: SGN - News) has just released to the news wires that it has received American Stock Exchange Approval for up to $102 million in financing with Yorkville Advisors, LLC through its YA Global Investments LP fund.
As part of the financing, Signalife has received immediate funding of $2 million through the sale of its common stock to YA Global Investments, and has also entered into a Standby Equity Distribution Agreement (SEDA) allowing Signalife, at its sole discretion upon effectiveness of a registration statement relating to the shares underlying the SEDA, to sale up to $100 million in additional common stock to YA Global Investments over the next three years. The company shall now proceed forward with its newly constituted Board and immediate sales initiative. The market should expect a status conference call from President and former FDA-head Lowell Harmison later this month or immediately after Labor Day.
When Dr. Harmison took the post, he promised immediate financing and he has delivered.
-------------------------------
G' day Mates,
Aussie
Thanks you Susie. Thought it was open to lal during happy hour. My mistake.
G' day Mate,
Aussie
Here's one to consider. PDEP. It has promising technology. But, like any penny stock, one must do their DD on it.
The company site for further DD:http://www.puredepth.com/
Today's PR from the company
PureDepth Secures Base Patent in China
BUSINESS WIRE
Posted: 2007-09-21 08:21:43
REDWOOD SHORES, Calif.--(BUSINESS WIRE)----PureDepth(TM), Inc. (OTC: PDEP), a global leader in next-generation display technologies and the pioneer of Multi-Layer Display (MLD(TM)) technology, today announced that it has been granted a patent for its base technology in China. The Chinese Patent Office awarded the Patent, Number 98813714.3, which encompasses the core technology upon which PureDepth's technology is developed. PureDepth's technology is now backed by a total of 49 granted patents.
http://money.aol.com/news/articles/_a/puredepth-secures-base-patent-in-china/n20070921082109990025
This is not a good report by any stretch of the imagination
PureDepth Announces Second Quarter Results
BUSINESS WIRE
Posted: 2007-09-17 08:23:20
REDWOOD SHORES, Calif.--(BUSINESS WIRE)----PureDepth(TM), Inc. (OTCBB: PDEP), a global leader in next-generation display technologies and the pioneer of Multi-Layer Display (MLD(TM)) technology, today announced financial results for the quarter and six months ended July 31, 2007.
"We feel we've made significant progress this quarter on our goal of getting our technology to the mass market. We continue to work closely with our existing licensing partners Sanyo and IGT to develop products for the location based entertainment markets and we continue to develop relationships with major LCD manufacturers that we believe will lead to the establishment of our MLD technology in various other markets including, computer monitors, public displays, mobile phones, automotive and televisions. We are confident that we will attain our goal of placing PureDepth's MLD technology in key markets worldwide," said Thomas L. Marcus, PureDepth's Chairman and CEO.
The Company reported total revenue of $308,719 for the second quarter ended July 31, 2007 of which $187,500 was revenue generated from technology licensing and $121,219 of revenue was generated from sales of products and services. The Company also reported a net loss of $2,807,076 or $0.04 per common share compared to a loss of $1,854,304 or $0.04 per common share for the same period of the previous fiscal year. The increase in the net loss was due primarily to increased costs associated with personnel and personnel related expenses for business development and engineering as well as professional services relating to public company filing requirements.
For the six months ended July 31, 2007, the Company reported total revenue of $540,317 and a net loss of $4,785,320, or $0.07 per share compared with a net loss of $5,531,854 for same six month period of the previous year, or $0.12 per share.
As of July 31, 2007, the Company reported cash and cash equivalents of $3,227,962 and marketable securities of $1,013,178.
http://money.aol.com/news/articles/_a/puredepth-announces-second-quarter/n20070917082309990019
This is their big fish.
http://ir.puredepth.com/releasedetail.cfm?ReleaseID=214922REDWOOD SHORES, Calif., Oct 17, 2006 (BUSINESS WIRE) -- PureDepth(TM), Inc. (OTC: PDEP), a leader in next-generation display technologies and the pioneer of multi-layer display (MLD(TM)) technology, today announced a worldwide agreement with International Game Technology (NYSE: IGT), a leading international provider of computerized, gaming machines and systems products.
Under the agreement, IGT is licensing PureDepth technology and patents in order to develop, manufacture, market, sell and distribute products for use in wager-based gaming. The license is worldwide (excluding Japan).
----------------------
G' day Mates,
Aussie
Matt,
I tried to post in the jailhouse as part of the happy hour and it wouldn't open up a posting box. Is there a glich?
Thanks.
G' day Mate,
Aussie
Jagman...HINT had what appears to be a recent double bottom base and broke out of the second base dramatically on 18 Sept 2007.
In checking their SMA charts for 13, 20 & 50 days, both lower SMAs broke above the 50, which looks real good. I generally use 7, 18 & 30; however, there is no difference for HINT.
It's On Balance Volume is starting to show upward movement; but, not enough yet.
And, the Williams %R is neutral.
And, their volume+ is only above average for September.
IMO, it is definitely one to watch.
Thanks for the HINT.
G' day Mate,
Aussie
Another to consider and, it has done much better recently. Since late August it has gone from $.80 to $1.30. However, please do your DD.
The company site
http://www.signalife.com/index.asp
Recent PR shows things may be looking up.
http://www.signalife.com/Pages/NewsPDF/2007/PR09202007.asp
Thursday September 20, 9:03 am ET
Signalife Achieves $1.98 Million Sales Orders Thus Far
LOS ANGELES, Sep. 20 /PRNewswire-FirstCall/ -- Signalife announced today that it has received orders for the sale of nearly $2,000,000 (two million dollars) of Fidelity 100 units thus far in its initial sales push being led by new management. Signalife, which anticipates additional sales orders resulting from its current efforts, shall announce such sales as and when they are completed.
9/6/07 · Legendary Earvin 'Magic' Johnson Joins AFL/Signalife Cardiovascular Protection Team - PR Newswire
This is just a PR. Didn't raise the PPS
http://money.aol.com/news/articles/_a/legendary-earvin-magic-johnson-joins/n20070906090709990014
9/4/07 · Signalife to Deploy Fidelity 100 Heart Monitors for AFL - PR Newswire
This was a good follow-up PR.
http://money.aol.com/news/articles/_a/signalife-to-deploy-fidelity-100-heart/n20070904105209990030
8/20/07 · Signalife Completes $102 Million Financing - PR Newswire
THIS IS THE PR! It clearly shows someone believes in the technology and puts the money up.
http://money.aol.com/news/articles/_a/signalife-to-deploy-fidelity-100-heart/n20070904105209990030
Signalife Completes $102 Million Financing
LOS ANGELES, Aug. 20 /PRNewswire-FirstCall/ -- Signalife, Inc. (Amex: SGN - News) has just released to the news wires that it has received American Stock Exchange Approval for up to $102 million in financing with Yorkville Advisors, LLC through its YA Global Investments LP fund.
As part of the financing, Signalife has received immediate funding of $2 million through the sale of its common stock to YA Global Investments, and has also entered into a Standby Equity Distribution Agreement (SEDA) allowing Signalife, at its sole discretion upon effectiveness of a registration statement relating to the shares underlying the SEDA, to sale up to $100 million in additional common stock to YA Global Investments over the next three years. The company shall now proceed forward with its newly constituted Board and immediate sales initiative. The market should expect a status conference call from President and former FDA-head Lowell Harmison later this month or immediately after Labor Day.
When Dr. Harmison took the post, he promised immediate financing and he has delivered.
-------------------------------
G' day Mates,
Aussie
Forgot, the company site for further DD:
http://www.puredepth.com/
G' day Mates,
Aussie
Here's one to consider. PDEP. It has promising technology. But, like any penny stock, one must do their DD on it.
Today's PR from the company
PureDepth Secures Base Patent in China
BUSINESS WIRE
Posted: 2007-09-21 08:21:43
REDWOOD SHORES, Calif.--(BUSINESS WIRE)----PureDepth(TM), Inc. (OTC: PDEP), a global leader in next-generation display technologies and the pioneer of Multi-Layer Display (MLD(TM)) technology, today announced that it has been granted a patent for its base technology in China. The Chinese Patent Office awarded the Patent, Number 98813714.3, which encompasses the core technology upon which PureDepth's technology is developed. PureDepth's technology is now backed by a total of 49 granted patents.
http://money.aol.com/news/articles/_a/puredepth-secures-base-patent-in-china/n20070921082109990025
This is not a good report by any stretch of the imagination
PureDepth Announces Second Quarter Results
BUSINESS WIRE
Posted: 2007-09-17 08:23:20
REDWOOD SHORES, Calif.--(BUSINESS WIRE)----PureDepth(TM), Inc. (OTCBB: PDEP), a global leader in next-generation display technologies and the pioneer of Multi-Layer Display (MLD(TM)) technology, today announced financial results for the quarter and six months ended July 31, 2007.
"We feel we've made significant progress this quarter on our goal of getting our technology to the mass market. We continue to work closely with our existing licensing partners Sanyo and IGT to develop products for the location based entertainment markets and we continue to develop relationships with major LCD manufacturers that we believe will lead to the establishment of our MLD technology in various other markets including, computer monitors, public displays, mobile phones, automotive and televisions. We are confident that we will attain our goal of placing PureDepth's MLD technology in key markets worldwide," said Thomas L. Marcus, PureDepth's Chairman and CEO.
The Company reported total revenue of $308,719 for the second quarter ended July 31, 2007 of which $187,500 was revenue generated from technology licensing and $121,219 of revenue was generated from sales of products and services. The Company also reported a net loss of $2,807,076 or $0.04 per common share compared to a loss of $1,854,304 or $0.04 per common share for the same period of the previous fiscal year. The increase in the net loss was due primarily to increased costs associated with personnel and personnel related expenses for business development and engineering as well as professional services relating to public company filing requirements.
For the six months ended July 31, 2007, the Company reported total revenue of $540,317 and a net loss of $4,785,320, or $0.07 per share compared with a net loss of $5,531,854 for same six month period of the previous year, or $0.12 per share.
As of July 31, 2007, the Company reported cash and cash equivalents of $3,227,962 and marketable securities of $1,013,178.
http://money.aol.com/news/articles/_a/puredepth-announces-second-quarter/n20070917082309990019
This is their big fish.
http://ir.puredepth.com/releasedetail.cfm?ReleaseID=214922REDWOOD SHORES, Calif., Oct 17, 2006 (BUSINESS WIRE) -- PureDepth(TM), Inc. (OTC: PDEP), a leader in next-generation display technologies and the pioneer of multi-layer display (MLD(TM)) technology, today announced a worldwide agreement with International Game Technology (NYSE: IGT), a leading international provider of computerized, gaming machines and systems products.
Under the agreement, IGT is licensing PureDepth technology and patents in order to develop, manufacture, market, sell and distribute products for use in wager-based gaming. The license is worldwide (excluding Japan).
----------------------
G' day Mates,
Aussie
P.S. -- I also have an email to IGT concerning their non-exclusive rights to use the MLD technology for casino administration, casino back-end systems and player tracking modules developed by PureDepth.
Will let the board know of any response.
G' day Mates,
Aussie
Doubloon...Right now, PDEP is doing poorly -- at $1.00.They would like IGT to get Nevada Gaming Board's approval and soon. However, neither they nor IGT have, as you know, any control over that.
Here is a copy of the email I received from PDEp's DeDe Sheel on 17 Sept 2007:
Thank you for your email and for your support of the Company. Management believes that IGT is on track with their implementation, but IGT controls the submission of products to the gaming commission and the announcement of their launch, and, for competitive reasons, they will only disclose approval and/or launch when it is most advantageous to do so. Unfortunately, sometimes these processes take longer than expected.
Management has been diligently working on assisting its current partners with the launch of their products as well as developing partnerships with top manufacturers of other products that can utilize its technology. The Company will announce any material events as quickly as, and to the extent, permitted by laws or legal agreements.
Again, thank you for your support and your patience while Management works to bring MLD technology to mass market. Please let me know if you have any other questions.
Thank you,
DeDe Sheel
G' day mate,
Aussie